CYduct Diagnostics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CYDX research report →
Price Chart
About the company
CYduct Diagnostics, Inc. operates as a medical instrument enterprise that engineers and commercializes a diverse range of technologies, equipment, and methodologies. These innovations are purposed for the detection, diagnosis, therapeutic intervention, and general management of various health conditions and illnesses.
- CEO
- Dom L. Gatto
- IPO
- 2000
- Employees
- 3
- HQ
- Westport, CT, US
Get TickerSpark's AI analysis on CYDX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.57M
- P/E
- -6.68
- PEG
- -0.12
- P/S
- 22.34
- P/B
- -3.63
- EV/EBITDA
- -14.68
- Div Yield
- 0.00%
- Gross Margin
- 62.32%
- Op Margin
- -220.10%
- Net Margin
- -294.73%
- ROE
- 8.29%
- ROIC
- 44.61%
Latest fiscal year · YoY change
- Revenue
- $70.37K-0.4%
- Gross Profit
- $43.85K-6.3%
- Op Income
- $-154,885
- Net Income
- $-207,401+49.9%
- EPS
- $-0.04+52.6%
- OCF Growth
- +116.0%
- FCF Growth
- +116.0%
- 52W High
- $2.90
- 52W Low
- $0.20
- 50D MA
- $1.22
- 200D MA
- $1.00
- Beta
- -0.93
- RSI (14)
- 9
- Avg Volume
- 2.47K
No earnings-call transcripts are available for CYDX yet.
- Free Float
- 96.3%
- Shares Outstanding
- 5.24M
- Float Shares
- 5.05M
Our CYDX coverage
Recent articles, reports, and earnings notes.
No research on CYDX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CYDX report →Cyduct Diagnostics To Participate at the 10th Annual Yale Innovation Summit
accesswire.com · May 16
CYduct Diagnostics Announces Positive Study Results for Biomarker Combinations in the Assessment of Breast Cancer
accesswire.com · Apr 2
CYduct Diagnostics Proudly Supports the "Find It Early Act" to Advance Women's Health
accesswire.com · Oct 31
CYduct Diagnostics Inc. Advocates for Breast Cancer Awareness Month: Pioneering Innovation and Early Detection
accesswire.com · Oct 19
Cyduct Diagnostics Recognizes a Visionary Leader in Breast Health: Dr. Susan Love
accesswire.com · Aug 1
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.